# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
JP Morgan analyst Eric Joseph maintains HilleVax (NASDAQ:HLVX) with a Overweight and raises the price target from $21 to $24.
HC Wainwright & Co. analyst Matthew Caufield reiterates HilleVax (NASDAQ:HLVX) with a Buy and maintains $28 price target.
HilleVax (NASDAQ:HLVX) reported quarterly losses of $(0.97) per share which missed the analyst consensus estimate of $(0.84) by...
HC Wainwright & Co. analyst Matthew Caufield reiterates HilleVax (NASDAQ:HLVX) with a Buy and maintains $28 price target.
HilleVax (NASDAQ:HLVX) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.83) by 6...
HC Wainwright & Co. analyst Matthew Caufield initiates coverage on HilleVax (NASDAQ:HLVX) with a Buy rating and announce...